|
Today's Headlines
Cardiac transplant patients may be at a higher risk for hospitalization due to drug-related problems than the general population, according to the results from a single cardiac transplant center, published the October issue of The Annals of Pharmacotherapy. » Full article
|
|
Half of the 3.2 billion prescriptions dispensed annually are not taken as prescribed. Pharmacy benefit leaders must reconsider the financial context of medication adherence and medication possession, according to industry leaders presenting at an online seminar for the Pharmacy Benefit Management Institute in October. » Full article
|
|
The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has updated its recommendations for pneumococcal vaccine in high-risk adults.
» Full article
|
|
Long-term treatment of folic acid and vitamin B6 and vitamin 12 had no statistically significant effect on colorectal adenoma among women who were at high risk for cardiovascular disease, according to recent study published in the Journal of the National Cancer Institute. » Full article
|
|
CONTINUING EDUCATION
Welcome to the second activity of our new CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 CPE credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The October activity will cover medical nutrition therapy, physical activity, and health maintenance considerations for patients with diabetes. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
Coming soon - All users will be required to provide their NABP e-Profile ID when logging into the Drug Topics' FREE CPE. This new process requires all pharmacists and pharmacy technicians to provide their NABP e-Profile ID prior to accessing the system. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.
|
|
EDITOR'S PICK
This article reviews the safety concerns that currently exist for FDA-approved incretin-based therapies and methods by which the pharmacist, an integral member in the inter-professional healthcare team, can ensure safe use, as well as the emerging uses, of incretin-based therapies. » Full article
|
Survey
a) Hardly ever
b) Once a week
c) Once a month
d) Once a day
Respond here and see what your colleagues think too.Want to see the results of our last survey. Click here.
|
|
|
Like
Tweet
